What does CUSIP 15117B202 represent in this 13F holders report?

CUSIP 15117B202 is the security identifier for CLDX - Celldex Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held CLDX - Celldex Therapeutics, Inc. - Common Stock in Q1 2021?

109 institutional investors reported CLDX - Celldex Therapeutics, Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Celldex Therapeutics, Inc. - Common Stock (CLDX)

CUSIP: 15117B202

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 67,629,115
Total 13F shares: 34,503,199
Share change: -2,290,040
Total reported value: $709,497,850
Put/Call ratio: 66%
Price per share: $20.60
Number of holders: 109
Value change: -$40,255,166
Number of buys: 55
Number of sells: 65

Quarterly Holders Quick Answers

What is CUSIP 15117B202?
CUSIP 15117B202 identifies CLDX - Celldex Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 15117B202:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CLDX - Celldex Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	5.1%	3,422,855	$59,968,000	—	31 Dec 2020	13F
Redmile Group, LLC	13F	Company	4%	2,711,616	$47,508,000	—	31 Dec 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	3.7%	2,500,000	$43,800,000	—	31 Dec 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	2.7%	1,837,108	$32,186,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	2.7%	1,810,260	$31,716,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	2.6%	1,767,915	$30,973,000	—	31 Dec 2020	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	2.4%	1,627,500	$28,514,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	2.1%	1,396,516	$24,467,000	—	31 Dec 2020	13F
Ikarian Capital, LLC	13F	Company	2%	1,364,990	$23,915,000	—	31 Dec 2020	13F
Vivo Capital, LLC	13F	Company	1.9%	1,291,875	$22,634,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	1.9%	1,281,624	$22,454,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.6%	1,048,827	$18,375,000	—	31 Dec 2020	13F
Octagon Capital Advisors LP	13F	Company	1.5%	1,041,398	$18,245,000	—	31 Dec 2020	13F
Boxer Capital, LLC	13F	Company	1.5%	1,000,000	$17,520,000	—	31 Dec 2020	13F
Polar Capital Holdings Plc	13F	Company	1.5%	1,000,000	$17,520,000	—	31 Dec 2020	13F
Opaleye Management Inc.	13F	Company	1.5%	992,000	$17,380,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	1.3%	861,381	$15,092,000	—	31 Dec 2020	13F
VR Adviser, LLC	13F	Company	1.2%	800,000	$14,016,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.95%	642,303	$11,253,000	—	31 Dec 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.88%	597,198	$10,463,000	—	31 Dec 2020	13F
Cresset Asset Management, LLC	13F	Company	0.68%	457,666	$8,018,000	—	31 Dec 2020	13F
TSP Capital Management Group, LLC	13F	Company	0.6%	403,229	$7,065,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.59%	401,556	$7,035,000	—	31 Dec 2020	13F
Artal Group S.A.	13F	Company	0.59%	400,000	$7,008,000	—	31 Dec 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.58%	393,215	$6,889,000	—	31 Dec 2020	13F
Commodore Capital LP	13F	Company	0.53%	356,431	$6,245,000	—	31 Dec 2020	13F
S.c.a. Candriam	13F	Individual	0.51%	344,139	$6,030,000	—	31 Dec 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.46%	311,737	$5,462,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.46%	307,915	$5,395,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.44%	299,054	$5,239,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.43%	293,068	$5,135,000	—	31 Dec 2020	13F
Altium Capital Management LLC	13F	Company	0.35%	239,520	$4,196,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.3%	205,922	$3,608,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.29%	196,792	$3,448,000	—	31 Dec 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.27%	179,670	$3,148,000	—	31 Dec 2020	13F
Verition Fund Management LLC	13F	Company	0.26%	175,539	$3,075,000	—	31 Dec 2020	13F
Qube Research & Technologies Ltd	13F	Company	0.25%	171,318	$3,001,000	—	31 Dec 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0.25%	170,591	$2,989,000	—	31 Dec 2020	13F
DSAM Partners (London) Ltd	13F	Company	0.25%	170,000	$2,978,000	—	31 Dec 2020	13F
Squarepoint Ops LLC	13F	Company	0.17%	114,764	$2,011,000	—	31 Dec 2020	13F
HRT FINANCIAL LP	13F	Company	0.15%	100,919	$1,768,000	—	31 Dec 2020	13F
Informed Momentum Co LLC	13F	Company	0.15%	100,259	$1,757,000	—	31 Dec 2020	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.14%	95,000	$1,664,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.14%	94,989	$1,664,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.14%	94,200	$1,650,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.13%	88,500	$1,551,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.13%	87,335	$1,530,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.12%	82,232	$1,441,000	—	31 Dec 2020	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	80,282	$1,407,000	—	31 Dec 2020	13F
Affinity Asset Advisors, LLC	13F	Company	0.11%	75,000	$1,314,000	—	31 Dec 2020	13F

Institutional Holders of Celldex Therapeutics, Inc. - Common Stock (CLDX) as of Q1 2021

As of 31 Mar 2021, Celldex Therapeutics, Inc. - Common Stock (CLDX) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,503,199 shares. The largest 10 holders included RTW INVESTMENTS, LP, Redmile Group, LLC, EVENTIDE ASSET MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, VANGUARD GROUP INC, Vivo Capital, LLC, VR Adviser, LLC, and ACUTA CAPITAL PARTNERS, LLC. This page lists 109 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

120

Q1 2021 holders

109

Holder diff

-11

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.